Studies and academic training

• 2015-2020 Doctoral studies (Dr. rer. nat.), Institute of Pharmacology, University Medical Center of Johannes Gutenberg University Mainz
• 2009-2015 Biomedical Chemistry (Diploma), Johannes Gutenberg University Mainz

Scientific career

• since 06/2024 Head of the working group Neuroepigenetics and RNA-based therapies (scientist), Institute of Neuroanatomy and Cell Biology, Hannover Medical School
• 10/2020-05/2024 Research associate, Developmental Neuroepigenetics Lab, Institute of Anatomy and Cell Biology, University of Freiburg, Germany
• 09/2015-02/2020 PhD student, Institute of Pharmacology, University Medical Center of the Johannes Gutenberg University Mainz
• 07/2015-08/2015 Research associate, Institute of Reconstructive Neurobiology, University of Bonn, Germany
• 02/2013-06/2013 Research associate (ERASMUS internship), Bäckvall group, Department of Organic Chemistry, University of Stockholm, Sweden

Scientific focus

1. Investigation of transcriptional, post-transcriptional and epigenetic regulation of gene expression during development and degeneration of the nervous system
2. Research and development of new RNA-based therapies
3. Development of various cell culture and organoid models for translational and personalized research in medicine

Online presence
ORCID: 0000-0001-9715-1582

Selected publications
ZFP982 confers mouse embryonic stem cell characteristics by regulating expression of Nanog, Zfp42, and Dppa3. Dehghanian F, Bovio PP, Gather F, Probst S, Naghsh-Nilchi A, Vogel T (2024) Biochim Biophys Acta Mol Cell Res. 1871(4):119686. https://doi.org/10.1016/j.bbamcr.2024.119686

Multimodal epigenetic changes and altered NEUROD1 chromatin binding in the mouse hippocampus underlie FOXG1 syndrome. Akol I, Izzo A, Gather F, Strack S, Heidrich S, Ó hAilín D, Villarreal A, Hacker C, Rauleac T, Bella C, Fischer A, Manke T, Vogel T (2023) Proc Natl Acad Sci U S A. 120(2):e2122467120. https://doi.org/10.1073/pnas.2122467120

A specific, non-immune system-related isoform of the human inducible nitric oxide synthase is expressed during differentiation of human stem cells into various cell types. Gather F, Ihrig-Biedert I, Kohlhas P, Krutenko T, Peitz M, Brüstle O, Pautz A, Kleinert H (2022) Cell Commun Signal. 20(1):47. https//doi.org/10.1186/s12964-022-00855-x

Paving Therapeutic Avenues for FOXG1 Syndrome: Untangling Genotypes and Phenotypes from a Molecular Perspective. Akol I, Gather F, Vogel T (2022) Int J Mol Sci. 23(2):954. https//doi.org/10.3390/ijms23020954

Regulation of human inducible nitric oxide synthase expression by an upstream open reading frame. Gather F, Schmitz K, Koch K, Vogt LM, Pautz A, Kleinert H (2019) Nitric Oxide. 88:50-60. https//doi.org/10.1016/j.niox.2019.04.008

The KH-type splicing regulatory protein (KSRP) regulates type III interferon expression post-transcriptionally.Schmidtke L, Schrick K, Saurin S, Käfer R, Gather F, Weinmann-Menke J, Kleinert H, Pautz A (2019) Biochem J. 476(2):333-352. https//doi.org/10.1042/BCJ20180522